|
| 36524989 | Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 37378664 | Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 36417763 | Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. | Blood Adv | 2023 |
| 35167654 | Guiding the global evolution of cytogenetic testing for hematologic malignancies. | Blood | 2022 |
| 35802949 | A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia. | Cancer Genet | 2022 |
| 35771717 | Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group. | Genes Chromosomes Cancer | 2022 |
| 35506873 | Apparent coexistence of <i>ETV6::RUNX1</i> and <i>KMT2A::MLLT3</i> fusions due to a nonproductive <i>KMT2A</i> rearrangement in B-ALL. | Leuk Lymphoma | 2022 |
| 36063163 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35101336 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 34907337 | Correction to: Recommendations for future extensions to the HGNC gene fusion nomenclature. | Leukemia | 2022 |
| 35304347 | Molecular Pathology Education: A Suggested Framework for Primary Care Resident Training in Genomic Medicine: A Report of the Association for Molecular Pathology Training and Education Committee. | J Mol Diagn | 2022 |
| 32886736 | Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. | Arch Pathol Lab Med | 2021 |
| 34764425 | Recommendations for future extensions to the HGNC gene fusion nomenclature. | Leukemia | 2021 |
| 34429303 | Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusion. | Cold Spring Harb Mol Case Stud | 2021 |
| 34131312 | Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 32302940 | Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia. | Cancer Genet | 2020 |
| 30554721 | GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome. | Am J Hum Genet | 2019 |
| 31160354 | Implementation of cancer next-generation sequencing testing in a community hospital. | Cold Spring Harb Mol Case Stud | 2019 |
| 29754767 | Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. | Am J Hum Genet | 2018 |
| 30455898 | A case for expanding carrier testing to include actionable X-linked disorders. | Clin Case Rep | 2018 |
| 28726804 | Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2017 |
| 27181684 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 27392081 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 21626672 | Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. | Am J Med Genet A | 2011 |
| 19738377 | Topo IIIalpha and BLM act within the Fanconi anemia pathway in response to DNA-crosslinking agents. | Cytogenet Genome Res | 2009 |
| 18180189 | Mammalian SNM1 is required for genome stability. | Mol Genet Metab | 2008 |
| 18758156 | Loss of homologous recombination or non-homologous end-joining leads to radial formation following DNA interstrand crosslink damage. | Cytogenet Genome Res | 2008 |
| 18672388 | ERCC1 is required for FANCD2 focus formation. | Mol Genet Metab | 2008 |
| 16382135 | Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. | Mol Cell Biol | 2006 |
| 16855632 | Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. | Leukemia | 2006 |
| 16919896 | CRELD2: gene mapping, alternate splicing, and comparative genomic identification of the promoter region. | Gene | 2006 |
| 16982743 | Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. | Cancer Res | 2006 |
| 16397136 | Natural gene therapy in monozygotic twins with Fanconi anemia. | Blood | 2006 |
| 16429406 | Novel inactivating mutations of FANCC in Brazilian patients with Fanconi anemia. | Hum Mutat | 2006 |
| 16216560 | In vivo genetic selection of renal proximal tubules. | Mol Ther | 2006 |
| 15665282 | Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. | Cancer Res | 2005 |
| 16135554 | Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. | Hum Mol Genet | 2005 |
| 15849801 | Y chromosome heterochromatin of differing lengths in two cell populations of the same individual. | Prenat Diagn | 2005 |
| 15084315 | Interstrand crosslink-induced radials form between non-homologous chromosomes, but are absent in sex chromosomes. | DNA Repair (Amst) | 2004 |
| 15195088 | Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. | Nat Med | 2004 |
| 15345865 | Fanconi Anemia: A Decade of Discoveries. | J Assoc Genet Technol | 2004 |
| 12665832 | Cell fusion is the principal source of bone-marrow-derived hepatocytes. | Nature | 2003 |
| 12967657 | siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells. | DNA Repair (Amst) | 2003 |
| 11749045 | The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. | Mol Genet Metab | 2001 |
| 11027296 | DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links. | Mol Cell Biol | 2000 |
| 15216894 | Gamma-tubulin at ten: progress and prospects. | Cell Struct Funct | 1999 |